Adults, adolescents & childn ≥10 yr w/ type 2 DM in combination w/ oral glucose-lowering drugs &/or insulin together w/ diet & exercise to provide adequate glycaemic control. Reduce risk of major adverse CV events eg, CV death, non-fatal MI & stroke in adults w/ type 2 diabetes who have established or at high risk for CV disease.
Not to be inj IV or IM. Not to be used in type 1 DM or diabetic ketoacidosis. Not an insulin substitute. Discontinue use if pancreatitis is suspected. Not recommended in CHF NYHA class IV, inflammatory bowel disease; diabetic gastroparesis. Increased risk of hypoglycaemia in combination w/ insulin or sulfonylurea. Preexisting thyroid disease. Ensure adequate fluid intake. May affect ability to drive & use machines. Not recommended in ESRD or severe hepatic impairment. Not to be used during pregnancy & lactation. Childn & adolescents <10 yr.
Sign Out
 6 mg_mL5bec0e5d-ecb6-4c3a-8fde-a915011c58d8.GIF)
